NVNONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
enVVeno Medical Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$7.69+0.22 (+2.95%)
Close on Oct 19, 2026
- Market cap
- $5.16M
- P/E (TTM)
- –
- Dividend yield
- –
enVVeno Medical Corp revenue by segment
By business segment
By product or service
| Revenue | Q4 19 | Q3 19 | Q2 19 | Q1 19 | Q4 18 | Q3 18 | Q2 18 | Q4 17 | Q3 17 | Q2 17 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Royalty Income [Member] | $0 | $0 | $0 | $31.24K | $28.06K | $28.06K | $28.96K | $43.12K | $27.88K | $38.80K | – | -100.0% |
| Product Sales [Member] | – | – | – | – | – | – | – | $32.40K | $0 | – | – | – |
| Contract Research - Related Party [Member] | – | – | – | – | $2.40K | $13.60K | $54.40K | – | – | – | – | – |
| Contract Research - Related Party [Member] | – | – | – | – | $2.40K | $13.60K | $54.40K | – | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of enVVeno Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.